1. Home
  2. SDST vs FEMY Comparison

SDST vs FEMY Comparison

Compare SDST & FEMY Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • SDST
  • FEMY
  • Stock Information
  • Founded
  • SDST 2022
  • FEMY 2004
  • Country
  • SDST United States
  • FEMY United States
  • Employees
  • SDST N/A
  • FEMY N/A
  • Industry
  • SDST Blank Checks
  • FEMY Medical/Dental Instruments
  • Sector
  • SDST Finance
  • FEMY Health Care
  • Exchange
  • SDST Nasdaq
  • FEMY Nasdaq
  • Market Cap
  • SDST 37.0M
  • FEMY 31.9M
  • IPO Year
  • SDST N/A
  • FEMY 2021
  • Fundamental
  • Price
  • SDST $0.21
  • FEMY $0.93
  • Analyst Decision
  • SDST Buy
  • FEMY Strong Buy
  • Analyst Count
  • SDST 2
  • FEMY 3
  • Target Price
  • SDST $1.70
  • FEMY $8.67
  • AVG Volume (30 Days)
  • SDST 4.5M
  • FEMY 421.2K
  • Earning Date
  • SDST 08-15-2025
  • FEMY 08-07-2025
  • Dividend Yield
  • SDST N/A
  • FEMY N/A
  • EPS Growth
  • SDST N/A
  • FEMY N/A
  • EPS
  • SDST N/A
  • FEMY N/A
  • Revenue
  • SDST N/A
  • FEMY $1,699,232.00
  • Revenue This Year
  • SDST $3,681.67
  • FEMY $231.84
  • Revenue Next Year
  • SDST N/A
  • FEMY $245.28
  • P/E Ratio
  • SDST N/A
  • FEMY N/A
  • Revenue Growth
  • SDST N/A
  • FEMY 61.97
  • 52 Week Low
  • SDST $0.14
  • FEMY $0.69
  • 52 Week High
  • SDST $28.38
  • FEMY $1.80
  • Technical
  • Relative Strength Index (RSI)
  • SDST N/A
  • FEMY 48.38
  • Support Level
  • SDST N/A
  • FEMY $0.85
  • Resistance Level
  • SDST N/A
  • FEMY $0.99
  • Average True Range (ATR)
  • SDST 0.00
  • FEMY 0.07
  • MACD
  • SDST 0.00
  • FEMY 0.01
  • Stochastic Oscillator
  • SDST 0.00
  • FEMY 32.52

About SDST Stardust Power Inc. Common Stock

Stardust Power Inc is developing a lithium refinery at its Facility in Muskogee, Oklahoma, with planned capacity of producing up to 50,000 metric tons per annum of BGLC once fully operational. The company will source lithium brine feedstock from various suppliers and may make investments upstream to secure additional feedstock. The Company seeks to sell its products to electric vehicle (EV) manufacturers as the primary market, with potential applications in other areas such as battery manufacturers, the U.S. military, and original equipment manufacturers (OEMs).

About FEMY Femasys Inc.

Femasys Inc is a biomedical company focused on transforming women's healthcare by developing solutions and advancements providing clinical impact to address severely underserved areas. The company's mission is to provide women with minimally invasive, non-surgical product technologies, accessible in the office, improving patient care and overall health economics. Its product portfolio includes FemaSeed Intratubal Insemination, an infertility treatment; FemVue, a companion diagnostic for fallopian tube assessment via ultrasound; FemBloc, a clinical product candidate being developed as a permanent birth control; FemCerv, a tissue sampler for cervical cancer diagnosis; and FemCath and FemChec. Geographically, it derives key revenue from the United States and rest from international markets.

Share on Social Networks: